ATE210429T1 - Therapie mittels gleichförmiger arzneistoffverabreichung - Google Patents

Therapie mittels gleichförmiger arzneistoffverabreichung

Info

Publication number
ATE210429T1
ATE210429T1 AT97916120T AT97916120T ATE210429T1 AT E210429 T1 ATE210429 T1 AT E210429T1 AT 97916120 T AT97916120 T AT 97916120T AT 97916120 T AT97916120 T AT 97916120T AT E210429 T1 ATE210429 T1 AT E210429T1
Authority
AT
Austria
Prior art keywords
drugs
therapy
uniform administration
administration
uniform
Prior art date
Application number
AT97916120T
Other languages
English (en)
Inventor
Atul Devdatt Ayer
Andrew Lam
Judy A Magruder
Lawrence G Hamel
Patrick S-L Wong
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE210429T1 publication Critical patent/ATE210429T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AT97916120T 1996-04-05 1997-03-20 Therapie mittels gleichförmiger arzneistoffverabreichung ATE210429T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1488996P 1996-04-05 1996-04-05
PCT/US1997/004495 WO1997037640A2 (en) 1996-04-05 1997-03-20 Uniform drug delivery therapy

Publications (1)

Publication Number Publication Date
ATE210429T1 true ATE210429T1 (de) 2001-12-15

Family

ID=21768382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97916120T ATE210429T1 (de) 1996-04-05 1997-03-20 Therapie mittels gleichförmiger arzneistoffverabreichung

Country Status (14)

Country Link
EP (1) EP0907358B1 (de)
JP (1) JP4262776B2 (de)
AR (1) AR006087A1 (de)
AT (1) ATE210429T1 (de)
AU (1) AU710389B2 (de)
BR (1) BR9708528A (de)
DE (1) DE69709101T2 (de)
DK (1) DK0907358T3 (de)
ES (1) ES2166988T3 (de)
HK (1) HK1020523A1 (de)
NZ (1) NZ332014A (de)
PT (1) PT907358E (de)
WO (1) WO1997037640A2 (de)
ZA (1) ZA97976B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
WO1999001120A1 (en) * 1997-07-01 1999-01-14 Pfizer Products Inc. Solubilized sertraline compositions
EA002482B1 (ru) 1997-07-01 2002-06-27 Пфайзер Инк. Соли сертралина и лекарственные формы с длительным высвобождением сертралина
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
KR100827254B1 (ko) * 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
RU2246295C2 (ru) * 1998-11-02 2005-02-20 Элзэ Копэрейшн Лекарственная форма c постоянной скоростью высвобождения лекарственного вещества, ядро лекарственной формы и способ обеспечения облегченного высвобождения лекарственного вещества из лекарственной формы
EP1233761B1 (de) * 1999-11-22 2007-03-28 ALZA Corporation Osmotische darreichungsform mit zwei mantelschichten
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
ATE547080T1 (de) 2000-08-30 2012-03-15 Univ Johns Hopkins Vorrichtungen zur intraokularen arzneimittelabgabe
EP1404301A4 (de) * 2001-06-21 2006-03-22 Andrx Pharmaceuticals Inc Pravastatin enthaltende stabile pharmazeutische zusammensetzungen mit kontrollierter freisetzung
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
GB2392385A (en) * 2002-09-02 2004-03-03 Cipla Ltd Pharmaceutical preparations comprising a 5HT uptake inhibitor and a homopolymer or copolymer of N-vinyl pyrrolidone
KR100795419B1 (ko) * 2006-01-03 2008-01-17 (주)네오메딕스 암로디핀 및 아스피린을 함유하는 약학 제제
US8747897B2 (en) * 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
MX351261B (es) 2012-06-01 2017-10-06 Surmodics Inc Aparato y método para recubrir catéteres con globo.
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
WO2014197744A1 (en) 2013-06-05 2014-12-11 Synchroneuron, Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2020112816A1 (en) 2018-11-29 2020-06-04 Surmodics, Inc. Apparatus and methods for coating medical devices
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices
EP4245300A4 (de) * 2022-01-31 2024-04-24 Sumitomo Seika Chemicals Zubereitungszusammensetzung mit kontrollierter wirkstofffreisetzung und zubereitung mit kontrollierter wirkstofffreisetzung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1503116A (en) * 1975-07-28 1978-03-08 Alza Corp Sustained release drug delivery devices
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs

Also Published As

Publication number Publication date
JP2000508313A (ja) 2000-07-04
AU2337897A (en) 1997-10-29
AR006087A1 (es) 1999-08-11
WO1997037640A3 (en) 1997-11-13
WO1997037640A2 (en) 1997-10-16
EP0907358A2 (de) 1999-04-14
HK1020523A1 (en) 2000-05-12
NZ332014A (en) 1999-04-29
BR9708528A (pt) 1999-08-03
DE69709101D1 (de) 2002-01-24
PT907358E (pt) 2002-05-31
AU710389B2 (en) 1999-09-16
JP4262776B2 (ja) 2009-05-13
DK0907358T3 (da) 2002-03-25
ZA97976B (en) 1997-08-18
ES2166988T3 (es) 2002-05-01
DE69709101T2 (de) 2002-04-25
EP0907358B1 (de) 2001-12-12

Similar Documents

Publication Publication Date Title
ATE210429T1 (de) Therapie mittels gleichförmiger arzneistoffverabreichung
DE69807634D1 (de) Medizinische einrichtung zur verabreichung von therapeutischen wirkstoffen
IT1283102B1 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
NO20003051D0 (no) Metode for administrering av AspB28-humant insulin
NO171269C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter
FR2769915B1 (fr) Derives d'indazole tricycliques, leur preparation et leur application en therapeutique
NO931186D0 (no) Terapeutisk aktive imidazolderivater, fremgangsmaate for deres fremstilling og anvendelse derav
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
NO995231D0 (no) Terapeutisk behandling av hudlidelser
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
GB9700737D0 (en) Administration of drugs
NO981564D0 (no) Terapeutisk administrering av hemoglobin ved hjertestans
IL117809A (en) Medical patch for rate-controlled transdermal administration of risperidone
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
FR2772377B1 (fr) Derives de 1-(1-h-imidazol-2-yl)pyrrolidines et 1-(1-h-imidazol-2-ylpiperidines), leur preparation et leur application en therapeutique
FR2772378B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
IT8809313A0 (it) Macchina per il trattamento terapeutico di lombalgie e lombosciatalgie
FR2753196B1 (fr) Derives d'indazole tricyclique, leur preparation et leur application en therapeutique
FR2755008B3 (fr) Pomme de douche pour massage et therapie
FR2769914B1 (fr) Derives d'indazole tricycliques leur preparation et leur application en therapeutique
FR2750427B1 (fr) Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique
DK0859595T3 (da) Terapeutisk præparat til transdermal indgivelse af aktive sfoffer gennem huden
FR2772760B1 (fr) Derives de 3-oxazol-5-yl-1-oxo-1,2-dihydroisoquinoleine-4- propanamide, leur preparation et leur application en therapeutique
DE29501910U1 (de) Transdermales therapeutisches den Wirkstoff Dimethisoquin enthaltendes System
SI0859595T1 (en) Therapeutic preparation for the transdermal administration of active substances

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification